Paper326260
Bone marrow transplantation in patients with gold-induced marrow aplasia.
Baldwin JL and 3 others. Arthritis Rheum, 1977. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. Bone marrow transplantation in patients with gold-induced marrow aplasia. Papers, record 326260. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326260
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia, Aplastic | Major topic |
| Bone Marrow Cells | Major topic |
| Bone Marrow Transplantation | Major topic |
| Gold | Major topic |
| Adult | |
| Arthritis, Rheumatoid | |
| Female | |
| Humans | |
| Middle Aged | |
| Salts | |
| Transplantation, Homologous |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39666176 | Measuring Patient Preferences to Inform Clinical Trial Design: An Example in Rheumatoid Arthritis. | Patient | 2025 | https://conductscience.org/library/papers/39666176 | PubMed |
| 32477335 | Prospects of the Use of Cell Therapy to Induce Immune Tolerance. | Front Immunol | 2020 | https://conductscience.org/library/papers/32477335 | PubMed |
| 29618462 | Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis. | Blood Adv | 2018 | https://conductscience.org/library/papers/29618462 | PubMed |
| 28228650 | Haematopoietic stem cell transplantation for autoimmune diseases. | Nat Rev Rheumatol | 2017 | https://conductscience.org/library/papers/28228650 | PubMed |
| 26460236 | Novel insights into a treatment for aplastic anemia based on the advanced proliferation of bone marrow‑derived mesenchymal stem cells induced by fibroblast growth factor 1. | Mol Med Rep | 2015 | https://conductscience.org/library/papers/26460236 | PubMed |
| 25146442 | Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review. | Clin Rev Allergy Immunol | 2014 | https://conductscience.org/library/papers/25146442 | PubMed |
| 19597421 | Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go. | Bone Marrow Transplant | 2009 | https://conductscience.org/library/papers/19597421 | PubMed |
| 19011875 | [Current value of stem-cell transplantation in autoimmune diseases]. | Z Rheumatol | 2008 | https://conductscience.org/library/papers/19011875 | PubMed |
| 15549303 | Non-myeloablative stem cell transplantation for autoimmune diseases. | Springer Semin Immunopathol | 2004 | https://conductscience.org/library/papers/15549303 | PubMed |
| 12931249 | Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens. | Bone Marrow Transplant | 2003 | https://conductscience.org/library/papers/12931249 | PubMed |
| 12931243 | Hematopoietic stem cell transplantation for severe rheumatoid arthritis. | Bone Marrow Transplant | 2003 | https://conductscience.org/library/papers/12931243 | PubMed |
| 12439698 | Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. | Bone Marrow Transplant | 2002 | https://conductscience.org/library/papers/12439698 | PubMed |
| 12430858 | Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? | Int J Hematol | 2002 | https://conductscience.org/library/papers/12430858 | PubMed |
| 12430846 | New strategies for BMT and organ transplantation. | Int J Hematol | 2002 | https://conductscience.org/library/papers/12430846 | PubMed |
| 10798603 | Does hemopoietic stem cell transplantation have a role in treatment of severe rheumatoid arthritis? | J Clin Immunol | 2000 | https://conductscience.org/library/papers/10798603 | PubMed |
| 9474474 | Optimisation of cyclophosphamide therapy in systemic vasculitis. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9474474 | PubMed |
| 8712875 | Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. | Ann Rheum Dis | 1996 | https://conductscience.org/library/papers/8712875 | PubMed |
| 8597773 | Prospects of immunotherapy for rheumatoid arthritis. | Pharm World Sci | 1995 | https://conductscience.org/library/papers/8597773 | PubMed |
| 3731724 | Gold-induced aplastic pancytopenia: 14-month survival through multiple transfusions. | Clin Rheumatol | 1986 | https://conductscience.org/library/papers/3731724 | PubMed |
| 3449312 | Gold-induced aplastic anemia. | Clin Rheumatol | 1987 | https://conductscience.org/library/papers/3449312 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/326260
GET https://conductscience.org/api/papers/v1/326260/cited_by?page=2